Konstantin Schneider

Konstantin Schneider

Auto-generated profile, based on publicly available information

Konstantin Schneider

Biochemical Engineering Institute, Saarland University, Saarbrücken, Germany

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Metabolic Engineering
Verified
Journal Article
Open access
IBIrina Borodina
Irina Borodina
KKKanchana Rueksomtawin Kildegaard
Kanchana Rueksomtawin Kildegaard
NJNiels B. Jensen
Niels B. Jensen
TBThomas H. Blicher
Thomas H. Blicher
JMJérôme Maury
Jérôme Maury
JNJens Nielsen
Jens Nielsen
Microbial fermentation of renewable feedstocks into plastic monomers can decrease our fossil dependence and reduce global CO2 emissions. 3-Hydroxypropionic acid (3HP) is a potential chemical building block for sustainable production of superabsorbent polymers and acrylic plastics. With the objective of developing Saccharomyces cerevisiae as an efficient cell factory for high-level production of 3HP, we identified the β-alanine biosynthetic route as the most economically attractive according to the metabolic modeling. We engineered and optimized a synthetic pathway for de novo biosynthesis of β-alanine and its subsequent conversion into 3HP using a novel β-alanine-pyruvate aminotransferase discovered in Bacillus cereus. The final strain produced 3HP at a titer of 13.7±0.3gL(-1) with a 0.14±0.0C-molC-mol(-1) yield on glucose in 80h in controlled fed-batch fermentation in mineral medium at pH 5, and this work therefore lays the basis for developing a process for biological 3HP production.

11 November 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MLMingji Li
Mingji Li
KSKonstantin Schneider
Konstantin Schneider
MKMette Kristensen
Mette Kristensen
IBIrina Borodina
Irina Borodina
JNJens Nielsen
Jens Nielsen
Stilbenoids, including resveratrol and its methylated derivatives, are natural potent antioxidants, produced by some plants in trace amounts as defense compounds. Extraction of stilbenoids from natural sources is costly due to their low abundance and often limited availability of the plant. Here we engineered the yeast Saccharomyces cerevisiae for production of stilbenoids on a simple mineral medium typically used for industrial production. We applied a pull-push-block strain engineering strategy that included overexpression of the resveratrol biosynthesis pathway, optimization of the electron transfer to the cytochrome P450 monooxygenase, increase of the precursors supply, and decrease of the pathway intermediates degradation. Fed-batch fermentation of the final strain resulted in a final titer of 800 mg l−1 resveratrol, which is by far the highest titer reported to date for production of resveratrol from glucose. We further integrated heterologous methyltransferases into the resveratrol platform strain and hereby demonstrated for the first time de novo biosynthesis of pinostilbene and pterostilbene, which have better stability and uptake in the human body, from glucose.

1 January 2017 in Metabolic Engineering
Verified
Journal Article
Closed access
HMHemanshu Mundhada
Hemanshu Mundhada
JSJose M. Seoane
Jose M. Seoane
KSKonstantin Schneider
Konstantin Schneider
AKAnna Koza
Anna Koza
HCHanne B. Christensen
Hanne B. Christensen
ANAlex Toftgaard Nielsen
Alex Toftgaard Nielsen

15 March 2016 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
KKKanchana Rueksomtawin Kildegaard
Kanchana Rueksomtawin Kildegaard
NJNiels B. Jensen
Niels B. Jensen
KSKonstantin Schneider
Konstantin Schneider
ECEik Czarnotta
Eik Czarnotta
EÖEmre Özdemir
Emre Özdemir
IBIrina Borodina
Irina Borodina
In the future, oil- and gas-derived polymers may be replaced with bio-based polymers, produced from renewable feedstocks using engineered cell factories. Acrylic acid and acrylic esters with an estimated world annual production of approximately 6 million tons by 2017 can be derived from 3-hydroxypropionic acid (3HP), which can be produced by microbial fermentation. For an economically viable process 3HP must be produced at high titer, rate and yield and preferably at low pH to minimize downstream processing costs. Here we describe the metabolic engineering of baker’s yeast Saccharomyces cerevisiae for biosynthesis of 3HP via a malonyl-CoA reductase (MCR)-dependent pathway. Integration of multiple copies of MCR from Chloroflexus aurantiacus and of phosphorylation-deficient acetyl-CoA carboxylase ACC1 genes into the genome of yeast increased 3HP titer fivefold in comparison with single integration. Furthermore we optimized the supply of acetyl-CoA by overexpressing native pyruvate decarboxylase PDC1, aldehyde dehydrogenase ALD6, and acetyl-CoA synthase from Salmonella enterica SEacs L641P . Finally we engineered the cofactor specificity of the glyceraldehyde-3-phosphate dehydrogenase to increase the intracellular production of NADPH at the expense of NADH and thus improve 3HP production and reduce formation of glycerol as by-product. The final strain produced 9.8 ± 0.4 g L−1 3HP with a yield of 13 % C-mol C-mol−1 glucose after 100 h in carbon-limited fed-batch cultivation at pH 5. The 3HP-producing strain was characterized by 13C metabolic flux analysis and by transcriptome analysis, which revealed some unexpected consequences of the undertaken metabolic engineering strategy, and based on this data, future metabolic engineering directions are proposed. In this study, S. cerevisiae was engineered for high-level production of 3HP by increasing the copy numbers of biosynthetic genes and improving flux towards precursors and redox cofactors. This strain represents a good platform for further optimization of 3HP production and hence an important step towards potential commercial bio-based production of 3HP.

1 February 2010 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
JNJens Niklas
Jens Niklas
KSKonstantin Schneider
Konstantin Schneider
EHElmar Heinzle
Elmar Heinzle

29 September 2015 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
HMHemanshu Mundhada
Hemanshu Mundhada
KSKonstantin Schneider
Konstantin Schneider
HCHanne Bjerre Christensen
Hanne Bjerre Christensen
ANAlex Toftgaard Nielsen
Alex Toftgaard Nielsen